CERo Therapeutics News

CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes

SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) ("CERo") an innovative immunotherapy company seeking to advance the next generation of engineered T cell

GlobeNewswireApr 30 21:00

CERo Therapeutics Files to Sell 26.62M Shares of Common Stock

Seeking AlphaApr 11 04:23

NVCR, SBNY and VITL Are Among After Hour Movers

Seeking AlphaApr 2 05:08

Trending Stocks Today: Avalo Therapeutics Shoots up 381.05%

March 28th - US stocks trending in regular trading hours.Gainers: $Avalo Therapeutics(AVTX.US)$ shoots up 381.05% to $22.85 with a turnover of $506.08 million. $Xilio Therapeutics(XLO.US)$ surges 130.

Futu NewsMar 29 02:05

KOD, ALLG and SST Among Mid-day Movers

Seeking AlphaMar 29 01:01

AVLX, SGH and ETNB Are Among Pre Market Losers

Seeking AlphaMar 16 04:48

RNLX, ASLN and SONN Among Pre-market Losers

Seeking AlphaMar 12 20:28

ELTK, PSTX and LTRN Among Mid-day Movers

Seeking AlphaMar 12 00:49

Lexicon Pharmaceuticals, Mesoblast, Ventyx Biosciences Among Healthcare Movers

Seeking AlphaMar 11 22:00

SOS, MFG and LYT Among Pre-market Losers

Seeking AlphaMar 11 20:26

Aptevo Therapeutics, Immuron, CASI Pharmaceuticals Among Healthcare Movers

Seeking AlphaMar 8 23:00

Top Premarket Gainers

Ainos (AIMD) shares surged more than 149%, reversing Thursday's slide. CERo Therapeutics (CERO) shares rose 55%, extending Thursday's rally. Gulf Island Fabrication (GIFI) shares advanced 27% after th

MT NewswiresMar 8 20:48

CERo Therapeutics (CERO) Sees Massive Volume & Price Surge on Preclinical Success

CERo Therapeutics Holdings, Inc. (NASDAQ: CERO) saw a meteoric rise yesterday, surging by a jaw-dropping 20.8%. However, the real fireworks ignited during the early premarket hours on Friday, as CERO catapulted by an astounding 54%, bringing its price close to $4.73. This astronomical surge was fueled by robust preclinical results, hinting at the promise of ...

Stocks TelegraphMar 8 18:49

Why CERo Therapeutics Stock Is Soaring

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares are racing higher Thursday after the company announced the publication of preclinical research on the use of its clinical candidate CER-1236 to tr

BenzingaMar 8 00:28

Viking Therapeutics, Creative Medical Technology, Aptorum Group Among Healthcare Movers

Seeking AlphaMar 7 23:01

CERo Therapeutics Shares Halted On Circuit Breaker

CERo Therapeutics Shares Halted On Circuit Breaker

BenzingaMar 7 22:47

Market-Moving News for March 7th

CERO: 838% | CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML PatientsBREA: 211% | Brera Holdings shares are tra

BenzingaMar 7 21:37

CERo Therapeutics Announced The Publication In Clinical Cancer Research A Paper Titled "Therapeutic Targeting of TIM-4-L With Engineered T CellsFor Acute Myeloid Leukemia."

CERo Therapeutics Announced The Publication In Clinical Cancer Research A Paper Titled "Therapeutic Targeting of TIM-4-L With Engineered T CellsFor Acute Myeloid Leukemia."

BenzingaMar 7 20:20

CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients

CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) ("CERo") an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms today

BusinesswireMar 7 20:00

SNCR, JANX and GBNH Among Mid-day Movers

Seeking AlphaFeb 22 01:27